0001828649-23-000005.txt : 20230814 0001828649-23-000005.hdr.sgml : 20230814 20230814115933 ACCESSION NUMBER: 0001828649-23-000005 CONFORMED SUBMISSION TYPE: C-U PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverge, Inc. CENTRAL INDEX KEY: 0001828649 IRS NUMBER: 822592905 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C-U SEC ACT: 1933 Act SEC FILE NUMBER: 020-32267 FILM NUMBER: 231167730 BUSINESS ADDRESS: STREET 1: 447 SUTTER ST. STE 405 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 8664151001 MAIL ADDRESS: STREET 1: 447 SUTTER ST STREET 2: STE 405 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 C-U 1 primary_doc.xml C-U 0001828649 XXXXXXXX 020-32267 LIVE false false false The Offering closed successfully on 8/8/2023, having received investment commitments of $138,007, although a final accounting has not taken place. Bioverge, Inc. Corporation DE 08-17-2017 447 SUTTER ST STE 405 SAN FRANCISCO CA 94108 https://bioverge.com/ N OpenDeal Portal LLC 0001751525 007-00167 283874 At the conclusion of the Offering, the Issuer shall pay the Intermediary a fee of six percent (6%) of the dollar amount raised in the Offering. The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the Offering. Other Crowd SAFE (Simple Agreement for Future Equity) 25000 1.00000 Arbitrary 25000.00 Y Other Other: At the Intermediary's discretion 1235000.00 08-07-2023 2.00 567769.00 751759.00 324314.00 487668.00 0.00 0.00 52668.00 178120.00 0.00 0.00 247786.00 251720.00 49972.00 26101.00 0.00 0.00 -406203.00 -591903.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Bioverge, Inc. Neil Littman President and CEO Neil Littman President and CEO 08-14-2023 Richard Gibb COO 08-14-2023